A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: A population-based cohort study (CCLG CNS9702)

Neuro-Oncology

Volumn 12, Issue 12, 2010, Pages 1257-1268

  Stokland, Tore ^a,b,g   Liu, Jo Fen ^a,b   Ironside, James W ^c   Ellison, David W ^f   Taylor, Roger ^d   Robinson, Kathryn J ^b   Picton, Susan V ^e   Walker, David A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d SWANSEA UNIVERSITY   (United Kingdom)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^f ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^g UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Children; Low grade astrocytoma; Low grade glioma; Multivariate; Prognostic factors

Indexed keywords

CARBOPLATIN; VINCRISTINE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; ASTROCYTOMA; BRAIN STEM; CANCER GRADING; CANCER RISK; CANCER SURGERY; CEREBELLUM; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; FEMALE; GLIOMA; HEMISPHERE; HISTOPATHOLOGY; HUMAN; HYPOTHALAMUS TUMOR; INFANT; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NEUROFIBROMATOSIS; OPTIC NERVE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POPULATION RESEARCH; PRESCHOOL CHILD; PROGNOSIS; PROGRESSION FREE SURVIVAL; RISK ASSESSMENT; SCHOOL CHILD; SPINAL CORD; TUMOR GROWTH; TUMOR LOCALIZATION; UNIVARIATE ANALYSIS;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; GLIOMA; HUMANS; INFANT; MALE; PILOT PROJECTS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 78650085358     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/noq092     Document Type: Article

References (41)

1. Stiller C. Childhood Cancer in Britain. Oxford: Oxford University Press;2007.
2. Louis DN, Ohgaaki H, Wiestler OD, Cavenee WK. WHO Classificationof Tumours of the Central Nervous System. 4th ed. Lyon: IARC; 2007.
3. Listernick R, Charrow J, Gutmann DH. Intracranial gliomas in neurofibromatosistype 1. Am J Med Genet. 1999;89(1):38-44.
4. Perilongo G, Moras P, Carollo C, et al. Spontaneous partial regression oflow-grade glioma in children with neurofibromatosis-1: a real possibility.J Child Neurol. 1999;14(6):352-356.
5. Rozen WM, Joseph S, Lo PA. Spontaneous regression of low-gradegliomas in pediatric patients without neurofibromatosis. PediatrNeurosurg. 2008;44(4):324-328.
6. Jenkin D, Angyalfi S, Becker L, et al. Optic glioma in children: surveillance,resection, or irradiation? Int J Radiat Oncol Biol Phys.1993;25(2):215-225.
7. Pollack IF, Claassen D, al Shboul Q, Janosky JE, Deutsch M. Low-gradegliomas of the cerebral hemispheres in children: an analysis of 71 cases.J Neurosurg. 1995;82(4):536-547.
8. Gajjar A, Sanford RA, Heideman R, et al. Low-grade astrocytoma: adecade of experience at St. Jude Children's Research Hospital. J ClinOncol. 1997;15(8):2792-2799.
9. Chan MY, Foong AP, Heisey DM, HarknessW, Hayward R, Michalski A.Potential prognostic factors of relapse-free survival in childhood opticpathway glioma: a multivariate analysis. Pediatr Neurosurg.1998;29(1):23-28.
10. Smoots DW, Geyer JR, Lieberman DM, Berger MS. Predicting diseaseprogression in childhood cerebellar astrocytoma. Childs Nerv Syst.1998;14(11):636-648.
11. Fouladi M, Wallace D, Langston JW, et al. Survival and functionaloutcome of children with hypothalamic/chiasmatic tumors. Cancer.2003;97(4):1084-1092.
12. Khafaga Y, Hassounah M, Kandil A, et al. Optic gliomas: a retrospectiveanalysis of 50 cases. Int J Radiat Oncol Biol Phys. 2003;56(3):807-812.
13. Fisher PG, Tihan T, Goldthwaite PT, et al. Outcome analysis of childhoodlow-grade astrocytomas. Pediatr Blood Cancer.2008;51(2):245-250.
14. Packer RJ, Ater J, Allen J, et al. Carboplatin and vincristine chemotherapyfor children with newly diagnosed progressive low-grade gliomas.J Neurosurg. 1997;86(5):747-754.
15. Gururangan S, Cavazos CM, Ashley D, et al. Phase II study of carboplatinin children with progressive low-grade gliomas. J Clin Oncol.2002;20(13):2951-2958.
16. Massimino M, Spreafico F, Cefalo G, et al. High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. J Clin Oncol.2002;20(20):4209-4216.
17. Fouladi M, Hunt DL, Pollack IF, et al. Outcome of children with centrallyreviewed low-grade gliomas treated with chemotherapy with orwithout radiotherapy on Children's Cancer Group high-grade gliomastudy CCG-945. Cancer. 2003;98(6):1243-1252.
18. Laithier V, Grill J, Le Deley MC, et al. Progression-free survival in childrenwith optic pathway tumors: dependence on age and the qualityof the response to chemotherapy-results of the first French prospectivestudy for the French Society of Pediatric Oncology. J Clin Oncol.2003;21(24):4572-4578.
19. Gnekow AK, Kortmann RD, Pietsch T, Emser A. Low gradechiasmatic- hypothalamic glioma-carboplatin and vincristin chemotherapyeffectively defers radiotherapy within a comprehensive treatmentstrategy-report from the multicenter treatment study for childrenand adolescents with a low grade glioma-HIT-LGG 1996-of theSociety of Pediatric Oncology and Hematology (GPOH). Klin Padiatr.2004;216(6):331-342.
20. Laws ER, Jr, Taylor WF, Clifton MB, Okazaki H. Neurosurgical managementof low-grade astrocytoma of the cerebral hemispheres. JNeurosurg. 1984;61(4):665-673.
21. Lote K, Egeland T, Hager B, et al. Survival, prognostic factors, andtherapeutic efficacy in low-grade glioma: a retrospective study in 379patients. J Clin Oncol. 1997;15(9):3129-3140.
22. Claus EB, Black PM. Survival rates and patterns of care for patients diagnosedwith supratentorial low-grade gliomas: data from the SEERprogram, 1973-2001. Cancer. 2006;106(6):1358-1363.
23. Gnekow AK. Recommendations of the Brain Tumor Subcommittee for thereporting of trials. SIOP Brain Tumor Subcommittee. International Societyof Pediatric Oncology. Med Pediatr Oncol. 1995;24(2):104-108.
24. Laupacis A, Wells G, Richardson WS, Tugwell P. Users' guides to themedical literature. V. How to use an article about prognosis.Evidence- BasedMedicineWorking Group. JAMA.1994;272(3):234-237.
25. Altman DG. Systematic reviews of evaluations of prognostic variables.Br Med J. 2001;323(7306):224-228.
26. Opocher E, Kremer LC, Da Dalt L, et al. Prognostic factors for progressionof childhood optic pathway glioma: a systematic review.Eur J Cancer. 2006;42(12):1807-1816.
27. Kaatsch P, Rickert CH, Kuhl J, Schuz J, Michaelis J. Population- basedepidemiologic data on brain tumors in German children. Cancer.2001;92(12): 3155-3164.
28. Rickert CH, Paulus W. Epidemiology of central nervous system tumorsin childhood and adolescence based on the new WHO classification.Childs Nerv Syst. 2001;17(9):503-511.
29. Rosemberg S, Fujiwara D. Epidemiology of pediatric tumors of the nervoussystem according to the WHO 2000 classification: a report of 1,195 casesfrom a single institution. Childs Nerv Syst. 2005;21(11):940-944.
30. Pfister S, Janzarik WG, Remke M, et al. BRAF gene duplication constitutesa mechanism of MAPK pathway activation in low-grade astrocytomas.J Clin Invest. 2008;118(5):1739-1749.
31. Sievert AJ, Jackson EM, Gai X, et al. Duplication of 7q34 in pediatriclow-grade astrocytomas detected by high-density single- nucleotidepolymorphism-based genotype arrays results in a novel BRAF fusiongene. Brain Pathol. 2009;19(3):449-458.
32. Jones DT, Kocialkowski S, Liu L, et al. Tandem duplication producing anovel oncogenic BRAF fusion gene defines the majority of pilocyticastrocytomas. Cancer Res. 2008;68(21):8673-8677.
33. Bar EE, Lin A, Tihan T, Burger PC, Eberhart CG. Frequent gains atchromosome 7q34 involving BRAF in pilocytic astrocytoma.J Neuropathol Exp Neurol. 2008;67(9):878-887.
34. Forshew T, Tatevossian RG, Lawson AR, et al. Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocyticastrocytomas. J Pathol. 2009;218(2):172-181.
35. Jones DT, Kocialkowski S, Liu L, Pearson DM, Ichimura K, Collins VP.Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternativesto KIAA1549:BRAF fusion in activating the MAPK pathway in pilocyticastrocytoma. Oncogene. 2009;28(20):2119-2123.
36. Tihan T, Fisher PG, Kepner JL, et al. Pediatric astrocytomas with monomorphouspilomyxoid features and a less favorable outcome.J Neuropathol Exp Neurol. 1999;58(10):1061-1068.
37. Komakula ST, Fenton LZ, Kleinschmidt-DeMasters BK, Foreman NK.Pilomyxoid astrocytoma: neuroimaging with clinicopathologic correlatesin 4 cases followed over time. J Pediatr Hematol Oncol.2007;29(7):465-470.
38. Scotting PJ, Walker DA, Perilongo G. Childhood solid tumours: a developmentaldisorder. Nat Rev Cancer. 2005;5(6):481-488.
39. Taylor T, Jaspan T, Milano G, et al. Radiological classification of opticpathway gliomas: experience of a modified functional classificationsystem. Br J Radiol. 2008;81(970):761-766.
40. Sharma MK, Mansur DB, Reifenberger G, et al. Distinct genetic signaturesamong pilocytic astrocytomas relate to their brain region origin.Cancer Res. 2007;67(3):890-900.
41. Warrington NM, Woerner BM, Daginakatte GC, et al. Spatiotemporaldifferences in CXCL12 expression and cyclic AMP underlie the uniquepattern of optic glioma growth in neurofibromatosis type CancerRes. 2007;67(18):8588-8595.